Showing results (11-20 of 76) with videos related to
Sort By:
Pageof 8
Journal of Virology|September 16, 2011
Vesicular stomatitis virus oncolytic treatment interferes with tumor-associated dendritic cell functions and abrogates tumor antigen presentationSimon Leveille, Marie-Line Goulet, Brian D Lichty, et al.Journal of Leukocyte Biology|December 5, 2014
Microvesicles: ubiquitous contributors to infection and immunityFrances W Lai, Brian D Lichty, Dawn M E BowdishJournal of Virology|October 11, 2013
Human coronavirus OC43 nucleocapsid protein binds microRNA 9 and potentiates NF-κB activationFrances W Lai, Kyle B Stephenson, James Mahony, et al.Trends in Molecular Medicine|May 4, 2004
Vesicular stomatitis virus: re-inventing the bulletBrian D Lichty, Anthony T Power, David F Stojdl, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus-vectored tuberculosis vaccineElizabeth K Roediger, Kapilan Kugathasan, XiZhong Zhang, et al.Veterinary Immunology and Immunopathology|February 2, 2016
Cancer immunology and canine malignant melanoma: A comparative reviewMatthew J Atherton, Joanna S Morris, Mark R McDermott, et al.Nature Reviews. Cancer|July 4, 2014
Going viral with cancer immunotherapyBrian D Lichty, Caroline J Breitbach, David F Stojdl, et al.ACS Biomaterials Science & Engineering|January 15, 2021
Consecutive Spray Drying to Produce Coated Dry Powder Vaccines Suitable for Oral AdministrationDaniel A LeClair, Emily D Cranston, Brian D Lichty, et al.Nature Reviews. Immunology|September 5, 2020
Immunological considerations for COVID-19 vaccine strategiesMangalakumari Jeyanathan, Sam Afkhami, Fiona Smaill, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 6, 2010
FimH can directly activate human and murine natural killer cells via TLR4M Firoz Mian, Nicole M Lauzon, David W Andrews, et al.Pageof 8